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Solid organ transplant recipients require constant
immunosuppression to prevent graft failure of the
transplanted organ. As a result, patients are at high
risk for infections, some that are extremely rare and
uncommon with unusual presentations. Herein, we
describe a pancreatic transplant patient who suffered
from an infection from a novel polyomavirus result-
ing in a unique constellation of symptoms and skin
manifestations. This patient and novel polyomavirus
have been previously reported but we revisit the case
to highlight the dermatologic manifestations for
dermatology providers who may similar patients.1
CASE REPORT
A 33-year-old woman who received a pancreatic
transplant for type 1 diabetes mellitus 11 months
prior presented with a 3-week history of fatigue,
myalgias, decreasing visual acuity, and progressive
motor weakness in her torso and lower extremities.
Her posttransplant course was complicated by cyto-
megalovirus (CMV) viremia treated with a course of
valganciclovir, which was completed 6 months
before presentation. She was in excellent health,
working as a teacher and exercising 3 days a week.
Two weeks before presentation, Hurricane Sandy
damaged her home in Hoboken, New Jersey with
more than a foot of floodwater forcing her to
evacuate on foot. For 3 weeks, she experienced
progressive fatigue, myalgias, and decreasing visual
acuity. She had no history of international travel,
illicit drug use, or direct exposure to domestic
animals or wildlife. Her medications included 2.5
mg of prednisone daily, mycophenolic acid, 180 mg
twice daily, and tacrolimus, 6 mg twice daily.
On presentation, she had symmetric motor weak-
ness in her upper and lower extremities and wasthe Departments of Dermatologya and Infectious Diseases,b
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10032. E-mail: ijd2101@cumc.columbia.edu.blind with the ability to detect only bright light.
Multiple 1- to 2.5-cm necrotic ulcers on the scalp,
face, and hands with pseudovesicular, inflammatory
borders (Fig 1) were present. Her workup was
notable for elevated aldolase to 325 U/L (normal,
1.0 to 7.5 U/L) and creatine kinase to 8000 U/L
(normal, 60 to 174 U/L). Her polymerase chain
reaction (PCR) test for HIV, Epstein Barr virus,
parvovirus, and CMV was negative, and there was
no evidence of antibodies to influenza, adenovirus,
mycoplasma, human T-lymphotropic virus or hu-
man herpesvirus 6. Her serologic workup for auto-
immune and connective tissue disease was also
negative. Electromyography indicated widespread
myopathy. A deltoid muscle biopsy found focal
acute vasculitis, microthrombosis, focal chronic peri-
vasculitis, and chronic myofiber changes including
myonecrosis, large hyperchromatic vascular endo-
thelial atypia, and myoatrophy consistent with
nonspecific myositis. Immunostaining for CMV,
herpes simplex virus, adenovirus, BK virus and
John Cunningham (JC) virus were negative.
Ophthalmologic examination found bilateral optic
neuropathy of ischemic or inflammatory origin and
extensive retinal vascular occlusions bilaterally. A
skin biopsy found ischemic dermopathy without
vasculitic or thrombotic features.
The patient was initially treated for a presumptive
diagnosis of systemic vasculitis of unknown cause
with 500 mg/d of methylprednisolone intravenously
without improvement. She underwent a 5-dayJAAD Case Reports 2015;1:S38-40.
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Fig 1. A, Multiple 1- to 2.5-cm necrotic ulcers on the scalp and face with pseudovesicular,
inflammatory borders. B, A 1.5-cm necrotic ulcer on the hand with pseudovesicular, inflam-
matory borders. C, Close up of necrotic ulcer with pseudovesicular, inflammatory borders in
hairline. D, Close up of necrotic ulcer with pseudovesicular, inflammatory borders on digit.
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muscle strength but no recovery of her vision. Repeat
deltoid muscle biopsy failed to detect CMV, entero-
viruses, cardioviruses, human polyomaviruses,
parvovirus B19, mycoplasma, and a broad range of
herpesviruses by PCR.
Because no cause could be found for these
symptoms, a search for a novel viral cause was
initiated. The W. Ian Lipkin virology laboratory at
Columbia University tested total nucleic acid samples
from the patient with high throughput sequencing
(Ion Torrent) after ribosomal RNA depletion to
enhance sensitivity for virus detection. For further
details of the methodology, please see Mishra et al.1
Ultimately, the Lipkin laboratory was able to clone
a circular double-stranded DNA viral genome,
comprising 5108 base pairs, with 80.7% overall
nucleotidehomologyof genome to the closest known
related chimp polyomaviruses. The virus identified in
this patient meets criteria for classification as a novel
polyomavirus and was tentatively named New Jerseypolyomavirus 2013 (NJPyMv-2013). In situ hybridiza-
tion confirmed the presence of viral signal in the
deltoid muscle and skin biopsies.1
The patient was discharged to a rehabilitation
facility where her motor strength continued to
improve but without recovery of her vision. Blood
collected 10 months after the onset of illness tested
positive for NJPyMv-2013 DNA. Assays of banked
sera from 35 multiple transfusion patients from the
New York Blood Center, 15 rhesus macaques housed
at Columbia, the patient’s roommate in Hoboken,
and her sexual partner found no evidence of
NJPyMv-2013 infection by PCR or serology.
DISCUSSION
The polyomaviruses most commonly associated
with human infection are BK virus and JC virus.2 BK
virus and JC virus infections occur in early life with
an exposure prevalence that exceeds 75% in adults
and can persist throughout life. Reactivation most
commonly occurs in immunosuppressed patients,
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AIDS or cancer, have had organ transplantation,
or are undergoing multiple sclerosis treatment.3
Polyomavirus infection is typically asymptomatic or
results in only a mild respiratory disease; however,
reactivation of BK virus has been implicated in renal
transplant allograft failure and hemorrhagic cystitis
in allogeneic hematopoietic stem cell transplant
recipients.4 BK virus is believed, in these cases, to
infect endothelial cells leading to ischemic vascul-
opathy, similar to the ischemic vasculopathy
observed in our patient.5 JC virus is noted to infect
oligodendrocytes and cause progressive multifocal
leukoencephalopathy.5
Recently, several dermatologic diseases attribut-
able to polyomaviruses have been reported. A
polyomavirus was found to be the causative agent
of Merkel cell carcinoma.5 A novel polyomavirus was
found to be associated with trichodysplasia spinu-
losa, a condition characterized by erythematous to
skin-colored papules with spiny projections usually
on the mid portion of the face, seen almost exclu-
sively in immunosuppressed patients.6 Human
polyomavirus 7 was recently reported to cause a
distinctive epidermal hyperplasia resulting in pru-
ritic, brown plaques on the trunk and extremities in 2
lung transplant recipients.7 Our case highlights the
clinical presentation of a unique polyomavirus
infection in a diabetic pancreatic transplant patient
who presented with myositis, blindness, and distinc-
tive necrotic ulcers with pseudovesicular inflamma-
tory borders on the scalp and face.
Dermatologists who care for immunosuppressed
patients should be aware of human polyomaviruses
as potential agents of disease. Moreover, the
close temporal relationship between Hurricane
Sandy and the onset of illness in our patient shouldnot be overlooked, particularly in light of the
observation that other polyomaviruses associated
with human disease have been identified in sewage-
contaminated water.8,9 We present this novel case to
highlight the potential risk in immunosuppressed
patients in the aftermath of natural disasters so that
dermatologists who care for transplant patients are
aware of this pathogen should there be future
transmission of NJPyMv-2013.
REFERENCES
1. Mishra N, Pereira M, Rhodes RH, et al. Identification of a novel
polyomavirus in a pancreatic transplant recipient with retinal
blindness and vasculitic myopathy. J Infect Dis. 2014;210(10):
1595-1599.
2. Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of
polyomaviruses in human disease. Virology. 2009;384:266-273.
3. Pinto M, Dobson S. BK and JC virus: a review. J Infect. 2014;
68(suppl 1):S2-S8.
4. Pham PT, Schaenman J, Pham PC. BK virus infection following
kidney transplantation: an overview of risk factors, screening
strategies, and therapeutic interventions. Curr Opin Organ
Transplant. 2014;19(4):401-412.
5. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a
polyomavirus in human Merkel cell carcinoma. Science. 2008;
319:1096-1100.
6. van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN,
Gorbalenya AE, Feltkamp MC. Discovery of a new human
polyomavirus associated with trichodysplasia spinulosa in an
immunocompromized patient. PLoS Pathog. 2010;6(7):
e1001024.
7. Ho J, Jedrych JJ, Feng H, et al. Human Polyomavirus
7-Associated Pruritic Rash and Viremia in Transplant Recipi-
ents. J Infect Dis. 2015;211:1560-1565.
8. Fratini M, Di Bonito P, La Rosa G. Oncogenic papillomavirus and
polyomavirus in water environments: is there a potential for
waterborne transmission? Food Environ Virol. 2013. doi: 10.
1007/s12560-013-9134-0. Published online November 30, 2013.
9. Sidhu JP, Ahmed W, Gernjak W, et al. Sewage pollution in
urban stormwater runoff as evident from the widespread
presence of multiple microbial and chemical source tracking
markers. Sci Total Environ. 2013;463e464:488-496.
